Enhancing the efficacy of antidepressants with psychotherapy

Journal of Psychopharmacology

Volumn 20, Issue 3 SUPPL., 2006, Pages 19-28

  Petersen, Timothy J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antidepressants; Cognitive behavioural therapy; Depression; Psychotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; BRAIN CORTEX; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COPING BEHAVIOR; DEPRESSION; DRUG EFFICACY; GUILT; HOPELESSNESS; HUMAN; IRRITABILITY; LIMBIC SYSTEM; MAINTENANCE THERAPY; MAJOR DEPRESSION; NEUROIMAGING; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; RELAPSE; REMISSION; REVIEW; SELF ESTEEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 33745961583     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806064314     Document Type: Review

References (34)

1. American Psychiatric Association (2000) Practice guideline for the treatment of patients with major depressive disorder, 2nd edn. American Psychiatric Association Publishing, Inc., Washington, DC, pp. 1-87
2. Beck A T, Ward C H, Mendelson M, Mock J, Erbauch J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571
3. Blackburn I M, Moore R G (1997) Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 171: 328-334
4. DeRubeis R J, Hollon S D, Amsterdam J D, Shelton R C, Young P R, Salomon R M, O'Reardon J P, Lovett M L, Gladis MM, Brown L L, Gallop R (2005) Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 62: 409-416
5. Endicott J, Spitzer R L, Fleiss J L, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33: 766-771
6. Evans M D, Hollon S D, DeRubeis R J, Piasecki J M, Grove W M, Garvey M J, Tuason V B (1992) Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49: 802-808
7. Fava G A (1999a) Well-being therapy: conceptual and technical issues. Psychother Psychosom 68: 171-179
8. Fava G A (1999b) Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 29: 47-61
9. Fava G A, Fabbri S, Sonino N (2002) Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry 26: 1019-1027
10. Fava G A, Rafanelli C, Grandi S, Canestrari R, Morphy MA (1998a) Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 155: 1443-1445
11. Fava G A, Rafanelli C, Grandi S, Conti S, Belluardo P (1998b) Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings. Arch Gen Psychiatry 55: 816-820
12. Fava G A, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S (2004) Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 161: 1872-1876
13. Frank E, Grochocinski V J, Spanier C A, Buysse D J, Cherry C R, Houck P R, Stapf D M, Kupfer D J (2000) Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression. J Clin Psychiatry 61: 51-57
14. Frank E, Kupfer D J, Perel J M, Cornes C, Jarrett D B, Mallinger A G, Thase M E, McEachran A B, Grochocinski V J (1990) Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47: 1093-1099
15. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61: 34-41
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
17. Hollon S D, Haman K L, Brown L L (2002) Cognitive-behavioral treatment of depression. In Gotlib I H, Hammen C L (eds), Handbook of Depression. The Guilford Press, New York
18. Hollon S D, Jarrett R B, Nierenberg A A, Thase M E, Trivedi M, Rush A J (2005a) Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 66: 455-468
19. Hollon S D, DeRubeis R J, Evans M D, Wiemer M J, Garvey M J, Grove W M, Tuason V B (1992) Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry 49: 774-781
20. Hollon S D, DeRubeis R J, Shelton R C, Amsterdam J D, Salomon R M, O'Reardon J P, Lovett M L, Young P R, Haman K L, Freeman B B, Gallop R (2005b) Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 62: 417-422
21. Keller M B, McCullough J P, Klein D N, Arnow B, Dunner D L, Gelenberg A J, Markowitz J C, Nemeroff C B, Russell J M, Thase M E, Trivedi M H, Zajecka J (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342: 1462-1470
22. Kocsis J H, Rush A J, Markowitz J C, Borian F E, Dunner D L, Koran L M, Klein D N, Trivedi M H, Arnow B, Keitner G, Kornstein S G, Keller M B (2003) Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacol Bull 37: 73-87
23. Kornbluh R, Papakostas G I, Petersen T, Neault N B, Nierenberg A A, Rosenbaum J F, Fava M (2001) A survey of prescribing preferences in the treatment of refractory depression: recent trends. Psychopharmacol Bull 35: 150-156
24. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292: 807-820
25. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 61: 714-719
26. Paykel E S, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25: 1171-1180
27. Paykel E S, Scott J, Teasdale J D, Johnson A L, Garland A, Moore R, Jenaway A, Cornwall P L, Hayhurst H, Abbott R, Pope M (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 56: 829-835
28. Petersen T, Harley R, Papakostas G I, Montoya H D, Fava M, Alpert J E (2004) Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychol Med 34: 555-561
29. Reynolds C F III, Frank E, Perel J M, Imber S D, Cornes C, Miller M D, Mazumdar S, Houck P R, Dew M A, Stack J A, Pollock B G, Kupfer D J (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281: 39-45
30. Scott J, Teasdale J D, Paykel E S, Johnson A L, Abbott R, Hayhurst H, Moore R, Garland A (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. Br J Psychiatry 177: 440-446
31. Segal Z, Vincent P, Levitt A (2002) Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci 27: 281-290
32. Teasdale J D, Scott J, Moore R G, Hayhurst H, Pope M, Paykel E S (2001) How does cognitive therapy prevent relapse in residual depression? Evidence from a controlled trial. J Consult Clin Psychol 69: 347-357
33. Teasdale J D, Segal Z V, Williams J M, Ridgeway V A, Soulsby J M, Lau M A (2000) Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 68: 615-623
34. Thase M E, Greenhouse J B, Frank E, Reynolds C F III, Pilkonis P A, Hurley K, Grochocinski V, Kupfer D J (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 54: 1009-1015